Citadel Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.37M Sell
37,627
-218,922
-85% -$7.96M ﹤0.01% 3019
2025
Q1
$9.29M Sell
256,549
-29,630
-10% -$1.07M ﹤0.01% 1300
2024
Q4
$12M Buy
286,179
+238,226
+497% +$10M ﹤0.01% 1210
2024
Q3
$2.66M Sell
47,953
-125,995
-72% -$7M ﹤0.01% 2257
2024
Q2
$7.15M Sell
173,948
-119,357
-41% -$4.91M ﹤0.01% 1428
2024
Q1
$13.7M Buy
293,305
+93,251
+47% +$4.35M ﹤0.01% 1099
2023
Q4
$9.57M Buy
200,054
+198,653
+14,179% +$9.5M ﹤0.01% 1259
2023
Q3
$49.9K Sell
1,401
-275,282
-99% -$9.81M ﹤0.01% 5081
2023
Q2
$12.8M Sell
276,683
-281,133
-50% -$13M ﹤0.01% 1053
2023
Q1
$22.4M Buy
557,816
+337,840
+154% +$13.5M ﹤0.01% 802
2022
Q4
$10.2M Buy
219,976
+36,970
+20% +$1.71M ﹤0.01% 1299
2022
Q3
$7.58M Sell
183,006
-834,297
-82% -$34.6M ﹤0.01% 1486
2022
Q2
$60.7M Sell
1,017,303
-297,729
-23% -$17.8M 0.02% 297
2022
Q1
$95.5M Sell
1,315,032
-128,415
-9% -$9.33M 0.02% 205
2021
Q4
$121M Sell
1,443,447
-39,703
-3% -$3.34M 0.02% 157
2021
Q3
$134M Sell
1,483,150
-373,329
-20% -$33.7M 0.03% 132
2021
Q2
$177M Buy
1,856,479
+911,966
+97% +$87M 0.04% 81
2021
Q1
$108M Buy
944,513
+438,003
+86% +$49.9M 0.03% 204
2020
Q4
$70.1M Buy
506,510
+57,123
+13% +$7.91M 0.02% 314
2020
Q3
$36.9M Sell
449,387
-207,833
-32% -$17.1M 0.01% 500
2020
Q2
$51.4M Sell
657,220
-969,888
-60% -$75.9M 0.02% 366
2020
Q1
$72.3M Buy
1,627,108
+128,466
+9% +$5.71M 0.03% 237
2019
Q4
$64M Buy
1,498,642
+1,059,896
+242% +$45.3M 0.03% 338
2019
Q3
$18.8M Sell
438,746
-45,320
-9% -$1.94M 0.01% 838
2019
Q2
$30.7M Sell
484,066
-490,006
-50% -$31.1M 0.01% 588
2019
Q1
$67.6M Buy
974,072
+963,599
+9,201% +$66.8M 0.03% 291
2018
Q4
$456K Sell
10,473
-182,348
-95% -$7.94M ﹤0.01% 3320
2018
Q3
$14.7M Sell
192,821
-274,751
-59% -$21M 0.01% 902
2018
Q2
$35.9M Sell
467,572
-17,007
-4% -$1.31M 0.02% 497
2018
Q1
$24.7M Buy
484,579
+190,219
+65% +$9.7M 0.01% 552
2017
Q4
$13.7M Buy
294,360
+269,271
+1,073% +$12.5M 0.01% 813
2017
Q3
$1.34M Buy
25,089
+20,746
+478% +$1.11M ﹤0.01% 2080
2017
Q2
$270K Sell
4,343
-6,238
-59% -$388K ﹤0.01% 2978
2017
Q1
$717K Buy
10,581
+7,074
+202% +$479K ﹤0.01% 2355
2016
Q4
$247K Sell
3,507
-977
-22% -$68.8K ﹤0.01% 2926
2016
Q3
$318K Buy
+4,484
New +$318K ﹤0.01% 2760
2016
Q2
Sell
-380,035
Closed -$24.1M 3790
2016
Q1
$24.1M Buy
380,035
+296,319
+354% +$18.8M 0.03% 410
2015
Q4
$9.39M Buy
83,716
+26,574
+47% +$2.98M 0.01% 876
2015
Q3
$5.5M Sell
57,142
-125,041
-69% -$12M 0.01% 1165
2015
Q2
$18.7M Sell
182,183
-439,290
-71% -$45M 0.02% 726
2015
Q1
$38.6M Buy
621,473
+248,618
+67% +$15.4M 0.04% 452
2014
Q4
$16.4M Buy
372,855
+164,112
+79% +$7.2M 0.02% 736
2014
Q3
$11.8M Buy
208,743
+2,168
+1% +$123K 0.01% 814
2014
Q2
$9.27M Buy
206,575
+154,023
+293% +$6.91M 0.01% 850
2014
Q1
$2.57M Buy
+52,552
New +$2.57M ﹤0.01% 1352